Ference et al. [18] carried out a large meta-analysis with 88,535 subjects in 8 randomized statin trials examining the role of KIF6 Trp719Arg allele in CHD and concluded that the risk allele increases the vulnerability to elevated LDL-C cholesterol. Here, KIF6 is linked to coronary artery disorder.